Toru Sugiyama Selected Research

Carboplatin (JM8)

1/2022	Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079).
11/2020	The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG.
1/2020	A phase 2 study of intraperitoneal carboplatin plus intravenous dose-dense paclitaxel in front-line treatment of suboptimal residual ovarian cancer.
10/2019	A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study).
6/2019	Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial Cancer at a High Risk of Progression: A Randomized Clinical Trial.
1/2019	The mesenchymal transition subtype more responsive to dose dense taxane chemotherapy combined with carboplatin than to conventional taxane and carboplatin chemotherapy in high grade serous ovarian carcinoma: A survey of Japanese Gynecologic Oncology Group study (JGOG3016A1).
1/2019	Bevacizumab combined with platinum-taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial).
8/2018	Safe administration of bevacizumab combination chemotherapy for the patients with recurrent cervical cancer after pelvic radiotherapy: Two case reports.
1/2018	Chemoresistance of Gastric-Type Mucinous Carcinoma of the Uterine Cervix: A Study of the Sankai Gynecology Study Group.
12/2016	Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toru Sugiyama Research Topics

Disease

76	Neoplasms (Cancer) 01/2022 - 08/2002
38	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2002
27	Carcinoma (Carcinomatosis) 01/2021 - 02/2002
26	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2022 - 01/2004
14	Ovarian Epithelial Carcinoma 11/2021 - 07/2002
11	Endometrial Neoplasms (Endometrial Cancer) 06/2019 - 08/2002
9	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2022 - 06/2008
8	Disease Progression 01/2022 - 10/2012
6	Adenocarcinoma 11/2019 - 08/2002
5	Mucinous Adenocarcinoma (Mucinous Carcinoma) 06/2018 - 09/2008
5	Neutropenia 01/2016 - 03/2011
5	Anemia 01/2014 - 12/2011
4	Fistula 09/2022 - 08/2018
4	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2018
4	Endometrioid Carcinoma 06/2018 - 09/2006
4	Lymphatic Metastasis 01/2018 - 06/2008
4	Nausea 09/2017 - 03/2015
4	Vomiting 09/2017 - 03/2015
4	Thrombocytopenia (Thrombopenia) 01/2016 - 03/2011
4	Carcinoid Tumor (Carcinoid) 10/2012 - 01/2010
4	Vascular System Injuries 07/2011 - 07/2004
3	Residual Neoplasm 11/2020 - 12/2006
3	Diarrhea 01/2016 - 02/2002
3	Leukopenia 01/2016 - 02/2002
3	Febrile Neutropenia 01/2016 - 02/2003
3	Ascites 07/2014 - 06/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2014 - 09/2005
3	Cushing Syndrome 01/2011 - 01/2010
3	Ectopic ACTH Syndrome 01/2011 - 01/2010
3	Pituitary ACTH Hypersecretion 01/2011 - 01/2010
3	Clear Cell Adenocarcinoma 07/2010 - 02/2010
2	Hypoxia (Hypoxemia) 11/2020 - 02/2010
2	Hypertension (High Blood Pressure) 08/2018 - 04/2007
2	Anorexia 09/2017 - 01/2016
2	Carcinogenesis 05/2016 - 03/2010
2	Carcinosarcoma 06/2015 - 12/2014
2	Sarcoma (Soft Tissue Sarcoma) 12/2014 - 01/2004
2	Adenoma (Adenomas) 01/2012 - 10/2010
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2011 - 01/2009
2	Insulinoma 01/2010 - 08/2005
2	Inflammation (Inflammations) 04/2007 - 10/2005
2	Obesity 10/2006 - 01/2005
2	Breast Neoplasms (Breast Cancer) 09/2006 - 10/2004
1	Herpes Simplex 03/2021
1	Adrenocortical Carcinoma 01/2021

Drug/Important Bio-Agent (IBA)

30	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 08/2005
30	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 02/2002
29	PlatinumIBA 01/2022 - 05/2003
23	Irinotecan (Camptosar)FDA LinkGeneric 11/2020 - 01/2002
18	Cisplatin (Platino)FDA LinkGeneric 11/2020 - 01/2002
14	taxaneIBA 10/2019 - 08/2007
12	Proteins (Proteins, Gene)FDA Link 06/2018 - 09/2006
10	Bevacizumab (Avastin)FDA Link 09/2022 - 02/2009
7	Pharmaceutical PreparationsIBA 01/2018 - 02/2002
6	liposomal doxorubicin (Doxil)FDA Link 11/2021 - 11/2008
6	Docetaxel (Taxotere)FDA Link 06/2019 - 11/2010
5	1-dodecylpyridoxal (PLD)IBA 11/2021 - 11/2008
5	AldosteroneIBA 01/2021 - 09/2005
5	Hormones (Hormone)IBA 01/2011 - 10/2004
4	Gemcitabine FDA Link 11/2021 - 01/2013
4	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2020 - 12/2006
4	nedaplatinIBA 08/2016 - 06/2008
4	Octreotide (Sandostatin)FDA LinkGeneric 01/2012 - 01/2009
4	Messenger RNA (mRNA)IBA 01/2012 - 09/2006
4	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2011 - 01/2010
3	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2019 - 06/2006
3	Biomarkers (Surrogate Marker)IBA 08/2017 - 02/2010
3	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2011 - 01/2010
3	Glucose (Dextrose)FDA LinkGeneric 01/2009 - 08/2005
2	AntigensIBA 01/2022 - 07/2016
2	Peptides (Polypeptides)IBA 11/2020 - 01/2004
2	AntiemeticsIBA 09/2017 - 03/2015
2	squamous cell carcinoma-related antigenIBA 07/2016 - 04/2015
2	Biological ProductsIBA 07/2013 - 08/2002
2	Antineoplastic Agents (Antineoplastics)IBA 01/2013 - 06/2012
2	TubulinIBA 03/2012 - 06/2008
2	Hemoglobins (Hemoglobin)IBA 12/2011 - 03/2011
2	Transcription Factors (Transcription Factor)IBA 01/2011 - 10/2010
2	EnzymesIBA 01/2011 - 01/2011
2	Insulin-Like PeptidesIBA 01/2011 - 01/2009
2	Etoposide (VP 16)FDA LinkGeneric 01/2011 - 08/2007
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2010 - 08/2005
2	Insulin (Novolin)FDA Link 10/2006 - 08/2005
1	NivolumabIBA 11/2021

Therapy/Procedure

54	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
35	Therapeutics 01/2022 - 10/2004
18	Hysterectomy 11/2019 - 12/2010
12	Neoadjuvant Therapy 01/2019 - 07/2002
9	Radiotherapy 09/2022 - 02/2003
5	Adjuvant Chemotherapy 06/2019 - 08/2002
5	Combination Drug Therapy (Combination Chemotherapy) 08/2018 - 05/2003
3	Cytoreduction Surgical Procedures 01/2020 - 07/2002
3	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 11/2007
3	Laparotomy 11/2017 - 07/2002
3	Trachelectomy 10/2016 - 08/2015
3	Chemoradiotherapy 08/2016 - 06/2008
2	Ovariectomy (Oophorectomy) 01/2018 - 07/2002
2	Salvage Therapy 05/2016 - 02/2003
2	Cesarean Section (Caesarean Section) 01/2012 - 05/2010
1	Re-Irradiation 09/2022